Plastics & Additives

Chicago latest to jump on plastic ban-wagon…sorta

By Kari Embree
Published: August 3rd, 2015

On August 1, Chicago’s partial ban went into effect which requires major retailers with more than 10,000 square feet to provide reusable or recyclable bags of any material or commercially compostable plastic bags, encouraging shoppers to be more eco-friendly. Smaller chains and franchises will have to comply next year, provided they are part of chain of at least three stores.

Has PHA’s time come?

By Karen Laird
Published: August 3rd, 2015

Scientists have known about polyhydroxyalkanoate (PHA) for a very long time. In fact, the simplest PHA, called P3HB, or sometimes just PHB, was discovered as early as 1926 by a French researcher, Maurice Lemoigne, in the course of his work with the bacterium Bacillus megaterium. At the time, little heed was paid to Lemoigne’s discovery, mainly because of  its perceived irrelevance: at the time, fossil fuels were inexpensive and abundant.

FDA approves first 3D-printed polymer implant for load-bearing applications

By PlasticsToday Staff
Published: August 3rd, 2015

Oxford Performance Materials Inc. (South Windsor, CT) has received 510(k) clearance from the FDA for its SpineFab system, a load-bearing polymer device for long-term implantation. Designed to replace a collapsed, damaged or unstable vertebral body caused by tumor or trauma, the vertebral body replacement (VBR) system is the first and only FDA-cleared 3D-printed device of its kind.

Berry Plastics to buy Avintiv for almost $2.5 billion

By PlasticsToday Staff
Published: July 31st, 2015

Berry Plastics Group Inc. (Evansville, IN) has entered into a definitive agreement to acquire Avintiv Inc. from the Blackstone Group LP for approximately $2.45 billion in cash on a debt-free, cash-free basis, the companies announced today.

Graphene: A wonder material struggles to find commercial applications

By Stephen Moore
Published: July 30th, 2015

Back in the 1990s, as a young journalist working for a chemical engineering magazine, I recall writing an article on Buckminsterfullerene (C60), otherwise known as Buckyballs. It was going to be the next biggest thing in materials according to many observers, finding applications in lubricants, high-temperature superconductors, reaction catalysts, and "disintegrating polymers" as I put it at the time.

Automotive foams market worth $41 billion by 2019

By Stephen Moore
Published: July 30th, 2015

The automotive foams market is forecast to grow by an average annual growth rate of 10.5% between 2014 and 2019 according to a report from Markets and Markets that pegs the total value of such materials shipped annually by then to reach $40.83 billion.

Solvay targets growth in automotive composites through Cytec acquisition

By Stephen Moore
Published: July 29th, 2015

Belgium's Solvay is acquiring composites and plastic additives manufacturer Cytec Industries for $5.5 billion through a cash merger with one of its subsidiaries. The transaction is expected to close in the fourth quarter of 2015.

Bio-on and Cristal Union sign 'sweet' bioplastics deal

By Karen Laird
Published: July 29th, 2015

Italy-based Bio-on, a biotechnology company specialized in the production of polyhydroxyalkanoates (PHAs), and French sugar producer Cristal Union, a grower-owned cooperative that produces a variety of products from sugar beets, have announced plans to establish France's first facility for the production of PHA bioplastics from sugar beet co-products.

Solvay starts up fluoroelastomers plant in China

By Stephen Moore
Published: July 28th, 2015

Solvay (Brussels, Belgium) has commenced production at a new fluoroelastomers plant in Changshu, China. The facility will manufacture the company's FKM type Tecnoflon products.

Red pill? Blue pill? How about a polymer pill that does it all?

By PlasticsToday Staff
Published: July 27th, 2015

Researchers at MIT's Koch Institute for Integrative Cancer Research and Massachusetts General Hospital (MGH) have created a polymer gel that could enable the development of long-acting devices that reside in the stomach, including orally delivered capsules that can release drugs over a number of days, weeks, or potentially months following a single administration. This breakthrough could go a long way toward improving patient adherence to long-term therapies for chronic illnesses.

Syndicate content

© 2011 UBM Canon | please visit these other sites

UBM Canon | Design News | Test & Measurement World | Packaging Digest | EDN | Qmed | Appliance Magazine | Powder Bulk Solids | Canon Trade Shows